| Mansour Nejadrasool, DPM | |
|
14600 Sherman Way Ste 230, Van Nuys, CA 91405 | |
| (818) 784-8420 | |
| (818) 785-0028 |
| Full Name | Mansour Nejadrasool |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 14600 Sherman Way Ste 230, Van Nuys, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477565828 | NPI | - | NPPES |
| 6445430003 | Other | CA | NORIDIAN SECOND PTAN FOR VAN NUYS CLINIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | E4452 (California) | Secondary |
| 213ES0131X | Podiatrist - Foot Surgery | E4452 (California) | Primary |
| Provider Name | Valley Foot Clinic Professional Corporation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689066581 PECOS PAC ID: 4688991029 Enrollment ID: O20150324002860 |
News Archive
A targeted effort to help high-risk heart failure patients stay on their medications did improve adherence to drug regimens, but had surprisingly little effect lowering hospital readmission rates, according to a study at Duke Medicine.
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation-conversion from one cell type to another-or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer.
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically-ill patients admitted to the intensive care unit (ICU).
A blood test that measures the amount of cell-free DNA (cfDNA) in the bloodstream - called a liquid biopsy - correlates with how patients will progress after they are diagnosed with glioblastoma (GBM), the deadliest and most common primary brain tumor in adults.
The New York State Health Department has announced the creation of six regional demonstration projects totaling $6.5 million in grant awards to help address the complex health care needs of Medicaid recipients with chronic illness or at-risk for disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mansour Nejadrasool, DPM 14600 Sherman Way Ste 230, Van Nuys, CA 91405-2291 Ph: (818) 784-8420 | Mansour Nejadrasool, DPM 14600 Sherman Way Ste 230, Van Nuys, CA 91405 Ph: (818) 784-8420 |
News Archive
A targeted effort to help high-risk heart failure patients stay on their medications did improve adherence to drug regimens, but had surprisingly little effect lowering hospital readmission rates, according to a study at Duke Medicine.
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation-conversion from one cell type to another-or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer.
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically-ill patients admitted to the intensive care unit (ICU).
A blood test that measures the amount of cell-free DNA (cfDNA) in the bloodstream - called a liquid biopsy - correlates with how patients will progress after they are diagnosed with glioblastoma (GBM), the deadliest and most common primary brain tumor in adults.
The New York State Health Department has announced the creation of six regional demonstration projects totaling $6.5 million in grant awards to help address the complex health care needs of Medicaid recipients with chronic illness or at-risk for disease.
› Verified 1 days ago
Ronald J Belczyk, Dpm Inc. Podiatrist Medicare: Medicare Enrolled Practice Location: 15107 Vanowen St, Van Nuys, CA 91405 Phone: 818-782-6600 Fax: 310-538-0929 | |
Better Steps Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 14550 Archwood St Ste A, Van Nuys, CA 91405 Phone: 818-220-7696 | |
Tae Hyun Kim, D P M INC Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13701 Burbank Blvd, Van Nuys, CA 91401 Phone: 818-997-1216 Fax: 818-997-4458 | |
Dr. Michael Blake Runyon, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 13701 Burbank Blvd, Van Nuys, CA 91401 Phone: 818-997-1216 Fax: 818-997-4458 | |
Lee C. Rogers, D.p.m., Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 15107 Vanowen St, Van Nuys, CA 91405 Phone: 818-782-6600 | |
Nicholas J Bevilacqua D P M Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 15107 Vanowen St, Van Nuys, CA 91405 Phone: 818-902-5755 Fax: 818-902-5766 | |
Tae Hyun Kim Dpm Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 13701 Burbank Blvd, Van Nuys, CA 91401 Phone: 818-997-1216 Fax: 818-997-4458 |